A registry for individuals with Down syndrome
Official title: DS-Connect®: The Down Syndrome Registry
Run by University of Colorado, Denver · NCT01950624 · Data updated 2026-11-12
This study is creating an online registry for people with Down syndrome to share their health information and connect with research opportunities that could improve care and understanding of the condition.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 100000 (estimated) |
| Sponsor | University of Colorado, Denver Academic / other |
| Locations | 1 site (Aurora, Colorado) |
| Status | Recruiting |
| Started | September 6, 2013 |
| Main results expected | June 2035 |
| Study ends | June 2035 |
| Registry record updated | January 31, 2025 |
| Trial ID | NCT01950624 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry include individuals of all ages with a diagnosis of Down syndrome, including those who can provide consent or have a legally authorized representative.
✕Probably not a fit
Patients who do not have a diagnosis of Down syndrome will not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
DS-Connect® is an online registry designed to collect demographic and health information from individuals with Down syndrome. The registry aims to identify various phenotypic manifestations of Down syndrome and connect individuals with potential research studies or clinical trials based on their health history. By participating, individuals and their families can share valuable insights that contribute to a better understanding of Down syndrome and its co-occurring conditions. This initiative fosters collaboration between the NIH, families, and researchers to enhance the quality of care and research opportunities for this population.
Why it matters
Potential benefit: If successful, this registry could significantly improve research participation and health outcomes for individuals with Down syndrome.
How similar studies have gone: Other similar registries have shown success in enhancing research participation and understanding of genetic conditions, making this approach promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
INCLUSION CRITERIA: * Adults (at least 18 years of age) with a diagnosis of DS (including mosaic DS or partial trisomy 21) who are capable of providing consent to participate, or for whom a legally authorized representative (LAR) may give permission on behalf of the individual to participate. Adults with DS who cannot consent for themselves but can provide assent would need to provide assent to their LAR. * Children (up to age 18 years of age) with a diagnosis of DS. Parents/guardians may enter registry information and give permission to participate on behalf of their child; if the child is over 7 years of age and able to provide assent, they must do so. (Note: Once a child has reached age 18, he or she will be prompted to re-enroll into the registry as an adult, if he/she is able to provide informed consent or with the consent of his/her LAR if unable to re-enroll themselves.) No individuals with DS will be excluded from taking part in DS-Connect based on age, race, ethnicity, or gender. EXCLUSION CRITERIA: * A person who does not have a diagnosis of DS (or mosaic DS or partial trisomy 21) * Adults with DS who are not capable of providing informed consent or assent to participate and do not have a Legally Authorized Representative who can do so. In the case where an adults with DS is able to provide assent but does not do so, that adult will be excluded. * A participant, parent, and/or LAR who cannot provide consent or does not read or understand a language that is available for the registry, either English or Spanish. * A child with DS (between the ages of 7 and 18 years) who is capable of providing assent but does not do so. * A child under the age of 18 years whose parents share joint custody and one parent indicates that they do not consent to the child's participation.
Where it's running
-
Linda Crnic Institute for Down Syndrome
Aurora, Colorado, United States Recruiting
Study contacts
- Principal investigator: Joaquin M Espinosa, Ph.D. — Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus
- Study coordinator: Anne Fiala
- Email: info@ds-connect.org
- Phone: (303) 724-6599
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Kinematic analysis of hand and arm movement in kids with Down syndrome, CP and healthy children
This study tests how well an instrumented Box and Block Test and motion tracking can measure upper-limb movement in healthy kids and those with pyramidal hemisyndrome or Down syndrome.
-
Sensory integration to help balance and movement in kids with Down syndrome
Aimed at seeing if adding sensory integration to physical therapy helps improve gross motor skills and balance in children with Down syndrome.
-
Collaboration for Down Syndrome Progress (CDP) in people with Down syndrome
A long-term study following people with Down syndrome of all ages to see how health and everyday life change over time.
-
JAK inhibitor treatment for Down syndrome in children and young adults
This study tests whether 6 months of tofacitinib can help improve safety and neurodevelopment in people with Down syndrome aged 6 to 22, compared with placebo.
-
Jump rope to improve navicular drop and foot posture in children with Down syndrome
This project will test whether adding jump-rope exercises to play activities helps improve foot posture in 4–15-year-old children with Down syndrome who have navicular drop.
-
Thymus removal and immune aging in people with Down syndrome
This study will try to see if removing part of the thymus affects immune health over time in people aged 1 and older with Down syndrome, comparing those who had thymectomy to those who did not and to unaffected household relatives.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.